Literature DB >> 8308709

Permeabilities of alkyl p-aminobenzoates through living skin equivalent and cadaver skin.

S D Roy1, J Fujiki, J S Fleitman.   

Abstract

The in vitro permeabilities of alkyl p-aminobenzoates through living skin equivalent (LSE) and cadaver skin were compared. Methyl, ethyl, and butyl p-aminobenzoates were used as model compounds. The permeabilities of these compounds through LSE and cadaver skin from an aqueous drug suspension were determined with a flow-through diffusion cell. The permeability coefficients of these esters in LSE were an order of magnitude higher than in cadaver skin. This was primarily because of low resistances offered by the outermost layer (i.e., stratum corneum) of LSE. In the case of cadaver skin, the permeability coefficient increased as the carbon chain length increased, whereas no appreciable change in the permeability coefficients of these esters in LSE was observed. These results clearly suggest that the LSE membrane offered very little resistance as opposed to cadaver skin. Therefore, the LSE membrane may not quantitatively represent a good human skin model for evaluating skin permeation of a drug from topical or transdermal formulations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8308709     DOI: 10.1002/jps.2600821217

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites.

Authors:  B Blumberg; H Kang; J Bolado; H Chen; A G Craig; T A Moreno; K Umesono; T Perlmann; E M De Robertis; R M Evans
Journal:  Genes Dev       Date:  1998-05-01       Impact factor: 11.361

Review 2.  Tissue-engineered human skin substitutes developed from collagen-populated hydrated gels: clinical and fundamental applications.

Authors:  F A Auger; M Rouabhia; F Goulet; F Berthod; V Moulin; L Germain
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

3.  Percutaneous delivery of thalidomide and its N-alkyl analogs.

Authors:  Colleen Goosen; Timothy J Laing; Jeanetta du Plessis; Theunis C Goosen; Guang-Wei Lu; Gordon L Flynn
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

4.  A novel in vitro percutaneous penetration model: evaluation of barrier properties with p-aminobenzoic acid and two of its derivatives.

Authors:  Miranda de Jager; Wouter Groenink; Ruth Bielsa i Guivernau; Elin Andersson; Nadezhda Angelova; Maria Ponec; Joke Bouwstra
Journal:  Pharm Res       Date:  2006-05-04       Impact factor: 4.200

5.  Effects of growth conditions on the barrier properties of a human skin equivalent.

Authors:  Priya Batheja; Yifan Song; Philip Wertz; Bozena Michniak-Kohn
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

Review 6.  Design for optimized topical delivery: Prodrugs and a paradigm change.

Authors:  Kenneth B Sloan; Scott C Wasdo; Jarkko Rautio
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.580

7.  Tissue engineered human skin equivalents.

Authors:  Zheng Zhang; Bozena B Michniak-Kohn
Journal:  Pharmaceutics       Date:  2012-01-06       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.